CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors (original) (raw)

• Weng AP, Ferrando AA, Lee W, Morris JPT, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269–271.
  Article CAS Google Scholar
• Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6: 314–322.
  Article CAS Google Scholar
• Jaleco AC, Neves H, Hooijberg E, Gameiro P, Clode N, Haury M et al. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 2001; 194: 991–1002.
  Article CAS Google Scholar
• Pear WS, Radtke F . Notch signaling in lymphopoiesis. Semin Immunol 2003; 15: 69–79.
  Article CAS Google Scholar
• Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11: 299–308.
  Article CAS Google Scholar
• Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, MacDonald HR et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10: 547–558.
  Article CAS Google Scholar
• Pear WS, Aster JC . T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004; 11: 426–433.
  Article CAS Google Scholar
• Schmitt TM, Ciofani M, Petrie HT, Zuniga-Pflucker JC . Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 2004; 200: 469–479.
  Article CAS Google Scholar
• Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F . Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. Immunity 2002; 16: 869–879.
  Article CAS Google Scholar
• Washburn T, Schweighoffer E, Gridley T, Chang D, Fowlkes BJ, Cado D et al. Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell 1997; 88: 833–843.
  Article CAS Google Scholar
• Deftos ML, Bevan MJ . Notch signaling in T cell development. Curr Opin Immunol 2000; 12: 166–172.
  Article CAS Google Scholar
• Fowlkes BJ, Robey EA . A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development. J Immunol 2002; 169: 1817–1821.
  Article CAS Google Scholar
• Izon DJ, Punt JA, Xu L, Karnell FG, Allman D, Myung PS et al. Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. Immunity 2001; 14: 253–264.
  Article CAS Google Scholar
• Robey E, Chang D, Itano A, Cado D, Alexander H, Lans D et al. An activated form of Notch influences the choice between CD4 and CD8T cell lineages. Cell 1996; 87: 483–492.
  Article CAS Google Scholar
• Fryer CJ, White JB, Jones KA . Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 2004; 16: 509–520.
  Article CAS Google Scholar
• Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649–661.
  Article CAS Google Scholar
• O'Neil J, Calvo J, McKenna K, Krishnamoorthy V, Aster JC, Bassing CH et al. Activating Notch1 mutations in mouse models of T-ALL. Blood 2006; 107: 781–785.
  Article CAS Google Scholar
• Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA . Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984; 311: 231–235.
  Article CAS Google Scholar
• Lin MH, Leimeister C, Gessler M, Kopan R . Activation of the Notch pathway in the hair cortex leads to aberrant differentiation of the adjacent hair-shaft layers. Development 2000; 127: 2421–2432.
  CAS PubMed Google Scholar
• Ferrando AA, Look AT . Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 2000; 37: 381–395.
  Article CAS Google Scholar
• Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535–1548.
  Article CAS Google Scholar
• Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994; 331: 1253–1258.
  Article CAS Google Scholar
• Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992; 80: 1090–1093.
  CAS Google Scholar
• Dopfer R, Henze G, Bender-Gotze C, Ebell W, Ehninger G, Friedrich W et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 1991; 78: 2780–2784.
  CAS PubMed Google Scholar
• Forman SJ, Schmidt GM, Nademanee AP, Amylon MD, Chao NJ, Fahey JL et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. J Clin Oncol 1991; 9: 1570–1574.
  Article CAS Google Scholar
• Schroeder H, Gustafsson G, Saarinen-Pihkala UM, Glomstein A, Jonmundsson G, Nysom K et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries. Bone Marrow Transplant 1999; 23: 555–560.
  Article CAS Google Scholar